(Portland, OR)  --  Researchers at the Oregon Health & Science University's Oregon National Primate Research Center say results of a clinical trial looking at the effect of a genetically-engineered antibody that attacks HIV have been promising.  The trial involved baby moneys infected with a version of HIV.  Researchers say the monkeys were later given the genetically-engineered antibodies, which killed the virus.  Scientists hope the discovery will eventually save the lives of human babies infected with HIV.